The global benzodiazepine drugs industry continues to witness steady growth due to the increasing prevalence of anxiety disorders, insomnia, seizure conditions, and alcohol withdrawal syndrome worldwide. Benzodiazepines remain among the most prescribed central nervous system medications because of their fast-acting sedative and anxiolytic properties. Rising awareness regarding mental health...
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt